<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">Int Ophthalmol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>International Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0165-5701</issn><issn pub-type="epub">1573-2630</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12064626</article-id><article-id pub-id-type="pmcid-ver">PMC12064626.1</article-id><article-id pub-id-type="pmcaid">12064626</article-id><article-id pub-id-type="pmcaiid">12064626</article-id><article-id pub-id-type="pmid">40343573</article-id><article-id pub-id-type="doi">10.1007/s10792-025-03539-w</article-id><article-id pub-id-type="publisher-id">3539</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Evaluat&#305;on of the protective role of melaton&#305;n &#305;n methanol &#305;nduced opt&#305;c neuropathy</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4071-5193</contrib-id><name name-style="western"><surname>Konuk</surname><given-names initials="&#x15E;G">&#350;erife G&#252;lhan</given-names></name><address><email>gulhan3855@hotmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8202-9955</contrib-id><name name-style="western"><surname>&#214;zdemir</surname><given-names initials="S">S&#252;leyman</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6671-9067</contrib-id><name name-style="western"><surname>K&#305;l&#305;&#231;</surname><given-names initials="R">Ra&#351;it</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0006-0097-9812</contrib-id><name name-style="western"><surname>Bektur</surname><given-names initials="G">Gamze</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9213-8805</contrib-id><name name-style="western"><surname>G&#252;ne&#351;</surname><given-names initials="A">Alper</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0950-6254</contrib-id><name name-style="western"><surname>&#350;ener</surname><given-names initials="E">Ender</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rpe9k96</institution-id><institution-id institution-id-type="GRID">grid.411550.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0689 906X</institution-id><institution>Faculty of Medicine, Department of Ophthalmology, </institution><institution>Tokat Gaziosmanpa&#351;a University, </institution></institution-wrap>Tokat, Turkey </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rpe9k96</institution-id><institution-id institution-id-type="GRID">grid.411550.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0689 906X</institution-id><institution>Faculty of Medicine, Department of Pathology, </institution><institution>Tokat Gaziosmanpa&#351;a University, </institution></institution-wrap>Tokat, Turkey </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>45</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">488324</issue-id><elocation-id>182</elocation-id><history><date date-type="received"><day>12</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>5</day><month>4</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>09</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>11</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-11 00:25:44.730"><day>11</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10792_2025_Article_3539.pdf"/><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">To investigate the effects of intraperitoneal melatonin administration on the optic nerve and retina following acute methanol exposure.</p></sec><sec><title>Materials and methods</title><p id="Par2">Twenty-four female albino Wistar rats weighing 200&#8211;300&#160;g and aged between 3 and 6&#160;months were utilized. The rats were divided into three groups, each consisting of eight rats: healthy control (C), methanol (M), and methanol&#8201;+&#8201;melatonin (MM) groups. Initially, rats in groups M and MM were administered intraperitoneal methotrexate at a dose of 0.3&#160;mg/kg. One week later, the same groups were orally given methanol at a concentration of 20% and a dose of 3&#160;g/kg to induce methanol toxicity. To ensure survival, four hours after oral methanol administration, ethanol was orally administered at a concentration of 20% and a dose of 0.5&#160;g/kg. Additionally, starting from the next day, the MM group received intraperitoneal melatonin at a dose of 20&#160;mg/kg/day for 14&#160;days. On the 14th day, rats were sacrificed, and their eyes, including the optic nerves, were enucleated for histopathological examinations. Myelin basic protein (MBP), retinal ganglion cell (RGC), glial cell degeneration and optic nerve thickness were evaluated.</p></sec><sec><title>Results</title><p id="Par3">The experiment was completed with a total of twenty-four rats, with each group consisting of eight rats. When evaluating RGC, glial cell degeneration, and optic nerve thickness, the results for Group MM were significantly better than those for Group M (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001, respectively). There was no significant difference between Group MM and Group C, which was not subjected to alcohol intoxication (<italic toggle="yes">p</italic>: 0.89, <italic toggle="yes">p</italic>: 0.82, <italic toggle="yes">p</italic>: 0.77, respectively). There was no significant difference in MBP values &#8203;&#8203;between the groups (<italic toggle="yes">p</italic>: 0.44, <italic toggle="yes">p</italic>: 0.17, <italic toggle="yes">p</italic>: 0.80, respectively).</p></sec><sec><title>Conclusion</title><p id="Par4">Intraperitoneal administration of melatonin has a significant positive effect on the structure of the retina and optic nerve resulting from methanol exposure. Melatonin should be considered in future studies as a potential therapy for methanol-induced toxic optic neuropathy.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Melatonin</kwd><kwd>Methanol</kwd><kwd>Optic neuropathy</kwd><kwd>Optic nerve</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group><funding-source><institution>Tokat Gaziosmanpa&#351;a University Scientific Research Project was supported financially.</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Tokat Gaziosmanpasa University</institution></funding-source></award-group><open-access><p>Open access funding provided by the Scientific and Technological Research Council of T&#252;rkiye (T&#220;B&#304;TAK).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature B.V. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Methanol poisoning occurs particularly in developing countries as a result of illegal consumption, suicide, or accidental intake of methanol [<xref ref-type="bibr" rid="CR1">1</xref>]. Poisoning, which has high morbidity and mortality rates, manifests symptoms such as nausea, vomiting, and abdominal pain within the first 4&#160;h. Central nervous system involvement and visual symptoms begin approximately 12&#160;h later [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Methanol poisoning can cause optic nerve and retinal damage, leading to symptoms ranging from blurred vision to total blindness. Symptoms may include photophobia, diplopia, and color vision impairment. The examination, optic nerve edema, hyperemia, pallor, and abnormalities in pupil reflex may be observed. Optic nerve atrophy develops slowly after toxic substance intake and usually completes within 30&#8211;60&#160;days [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par6">Various antidotes such as ethanol are used for the treatment of methanol poisoning; however, there is currently no defined effective treatment method for toxic optic neuropathy caused by methanol [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par7">Melatonin, secreted from the pineal gland, is a neurohormone responsible for regulating circadian rhythm and possesses antioxidant, anti-inflammatory, immunomodulatory, and neuroprotective properties [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. It has been shown in various studies that melatonin is produced in accordance with the circadian rhythm in the eye and receptors are present in various tissues of the eye [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Studies have also shown that melatonin provides neuroprotection in the eye and protects retinal ganglion cells [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par8">Based on this information, we researched the effects of melatonin on the optic nerve and retinal damage resulting from methanol. To our knowledge, this is the first study in the literature assessing the protective effects of melatonin in methanol-induced optic neuropathy.</p></sec><sec id="Sec2"><title>Method</title><p id="Par9">This research adhered to the principles outlined in the NIH statement for the Use of Animals in Research. Ethical approval for the study was obtained from the Animal Experimentation Ethics Committee of Tokat Gaziosmanpa&#351;a University (Approval No: 2022 HADYEK-09).</p><p id="Par10">Twenty four female Wistar albino rats, aged between 3 and 6&#160;months and weighing 200&#8211;300&#160;g, were utilized for the study. The rats were housed under standard laboratory conditions, which included a 12-h light&#8211;dark cycle, ambient light, and a room temperature of 20&#8211;22&#160;&#176;C.</p><p id="Par11">The rats were divided into three groups, each consisting of 8 rats: Groups C, M, and MM. Group C served as the healthy control group and received no agents. Group M received methanol, ethanol, and methotrexate, while Group MM received melatonin treatment in addition to the agents administered to Group M. Initially, rats in Groups M and MM were given intraperitoneal methotrexate at a dose of 0.3&#160;mg/kg. One week later, the same groups were orally administered methanol at a concentration of 20% and a dose of 3&#160;g/kg to induce toxicity. To ensure survival, 4&#160;h after oral methanol administration, oral ethanol at a concentration of 20% and a dose of 0.5&#160;g/kg was administered to all groups. Additionally, starting from the next day, Group MM received intraperitoneal melatonin at a dose of 20&#160;mg/kg/day for 14&#160;days.</p><p id="Par12">Methotrexate, a folic acid antagonist, was administered to sensitize rats to methanol toxicity since rats are folate-rich species and have low sensitivity to methanol intoxication [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par13">At the end of the procedure, the rats were injected with 50&#160;mg/kg intraperitoneal (i.p.) ketamine hydrochloride and 7.5&#160;mg/kg i.p. xylazine for anesthesia. Following the attainment of appropriate anesthetic depth, the right eyes of all twenty-four rats from each group were enucleated under anesthesia. After enucleation, a conjunctival peritomy was performed by circumferentially cutting the conjunctiva, followed by dissection of the optic nerve posteriorly after optic nerve transection. Following the procedure, the experimental animals were euthanized by cervical dislocation under ketamine and xylazine anesthesia.</p></sec><sec id="Sec3"><title>Histopathological examination</title><p id="Par14">The orbital samples were embedded in paraffin after dissection. The obtained samples were stained with hematoxylin and eosin. The evaluation was performed by a pathologist under a light microscope (Nikon ECLIPSE E200). For retinal assessment, the scoring system described by El-Bakary et al. was utilized for evaluating the ganglion cell layer. In the semi-quantitative examination: a score of 5 was assigned for a regular appearance in ganglion cells, a score of 4 for irregular appearance and vacuolization in less than 50% of cells, a score of 3 for irregularity in 50&#8211;80% of cells and vacuolization in less than 20% of cells, a score of 2 for irregularity in more than 80% of cells, vacuolization in more than 50% of cells, and swelling in less than 50% of cells, and a score of 1 for irregularity in more than 80% of cells, vacuolization in more than 50% of cells, and swelling [<xref ref-type="bibr" rid="CR13">13</xref>] (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Retinal specimen <bold>A</bold> The control group specimen shows normal structure and no cellular swelling (score 5/5), <bold>B</bold> Group MM specimen shows severe structural anomaly, cellular swelling and vacuolation (score 1/5), <bold>C</bold> Group M specimen shows mild structural anomaly, cellular swelling and vacuolation (score 4/5). GCL (ganglion cell layer), INL (internal nuclear lamina), ONL (outer nuclear lamina), 400X</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="10792_2025_3539_Fig1_HTML.jpg"/></fig></p><p id="Par15">In optic nerve samples, thickness increase and glial cell degeneration findings were evaluated semi-quantitatively. Each of these two parameters was evaluated separately as normal (score 0), mild degeneration or thickness increase (score 1), moderate degeneration or thickness increase (score 2), and severe degeneration or thickness increase (score 3) (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). In the immunohistochemical study conducted to assess optic nerve damage, myelin basic protein (clone: YN01146m, Elabscience, USA) was applied to the samples using the Leica BOND-MAX device to demonstrate preserved myelin material. Staining intensity was evaluated as strong (score 3), moderate (score 2), and weak (score 1) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Optic nerve tissue. <bold>A</bold> Control specimen showing no sign of glial cell degeneration or thicken ing, (score 0), <bold>B</bold> Group 1 specimen shows severe glial cell degeneration (arrows) and vacuolization (star), (score 3), <bold>C</bold> Group 2 specimen shows minimal glial cell degeneration (arrows), (score 1), 400X</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="10792_2025_3539_Fig2_HTML.jpg"/></fig><fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p><bold>A</bold> Strong myelin basic protein expression on optic nerve tissue from control group specimen (score 3), 400X. <bold>B</bold> Moderate myelin basic protein expression on optic nerve tissue from group 1 specimen (score 2), 400x</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="10792_2025_3539_Fig3_HTML.jpg"/></fig></p></sec><sec id="Sec4"><title>Statistical analysis</title><p id="Par16">Statistical analysis of the data was performed using SPSS (version 22.0; SPSS, Chicago, Illinois, USA). Numerical variables were summarized using mean&#8201;&#177;&#8201;standard deviation, median, and minimum&#8211;maximum values, while categorical variables were summarized using counts and percentages. The normality of the numerical data was assessed using the Kolmogorov&#8211;Smirnov test. One-way analysis of variance was used for comparisons among groups, followed by Tukey&#8217;s post hoc test. Statistical significance was set at <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05.</p></sec><sec id="Sec5"><title>Result</title><p id="Par17">A total of twenty four rats were enrolled in the study, and the study was completed without any loss. The results of the pathological evaluation are summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. There was no significant difference observed in MBP values among the groups. While there was no difference in optic nerve thickness between the C and MM groups, it was significantly thicker in Group M compared to both the C and MM groups. Furthermore, there was no difference in glial cell degeneration and RGC involvement in the optic nerve between the C and MM groups, whereas it was significantly better compared to Group M (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Results of pathological analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Group C</th><th align="left" colspan="1" rowspan="1">Group M</th><th align="left" colspan="1" rowspan="1">Group MM</th><th align="left" colspan="1" rowspan="1">p1</th><th align="left" colspan="1" rowspan="1">p2</th><th align="left" colspan="1" rowspan="1">p3</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">MBP</td><td char="." align="char" colspan="1" rowspan="1">3.00&#8201;&#177;&#8201;00</td><td char="." align="char" colspan="1" rowspan="1">2.75&#8201;&#177;&#8201;0.46</td><td char="." align="char" colspan="1" rowspan="1">2.62&#8201;&#177;&#8201;0.41</td><td char="." align="char" colspan="1" rowspan="1">0.44</td><td char="." align="char" colspan="1" rowspan="1">0.17</td><td char="." align="char" colspan="1" rowspan="1">0.80</td></tr><tr><td align="left" colspan="1" rowspan="1">Optic nerve thickness</td><td char="." align="char" colspan="1" rowspan="1">0.0&#8201;&#177;&#8201;0.0</td><td char="." align="char" colspan="1" rowspan="1">1.62&#8201;&#177;&#8201;0.51</td><td char="." align="char" colspan="1" rowspan="1">0.12&#8201;&#177;&#8201;0.35</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.00</bold><sup><bold>*</bold></sup></td><td char="." align="char" colspan="1" rowspan="1">0.77</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.00</bold><sup><bold>*</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Glial cell degeneration</td><td char="." align="char" colspan="1" rowspan="1">0.0&#8201;&#177;&#8201;0.0</td><td char="." align="char" colspan="1" rowspan="1">1.87&#8201;&#177;&#8201;0.64</td><td char="." align="char" colspan="1" rowspan="1">0.12&#8201;&#177;&#8201;0.35</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.00</bold><sup><bold>*</bold></sup></td><td char="." align="char" colspan="1" rowspan="1">0.82</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.00</bold><sup><bold>*</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">RGC</td><td char="." align="char" colspan="1" rowspan="1">5.0&#8201;&#177;&#8201;0.0</td><td char="." align="char" colspan="1" rowspan="1">2.25&#8201;&#177;&#8201;0.88</td><td char="." align="char" colspan="1" rowspan="1">4.87&#8201;&#177;&#8201;0.35</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.00</bold><sup><bold>*</bold></sup></td><td char="." align="char" colspan="1" rowspan="1">0.89</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.00</bold><sup><bold>*</bold></sup></td></tr></tbody></table><table-wrap-foot><p>C, control group; M, methanol group; MM, methanol-melatonin group; MPB, myelin basic protein; RGC, retinal ganglion cell</p><p>*Statistically significant; p1, significance level of the comparison between C and M groups; p2, significance level of the comparison between C and MM groups; p3, significance level of the comparison between M and MM groups</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec6"><title>Discussion</title><p id="Par18">In our study, we investigated the protective and therapeutic effects of melatonin use on methanol induced optic neuropathy.</p><p id="Par19">When examining the pathogenesis of alcohol poisoning, the alcohol dehydrogenase enzyme oxidizes methanol to formaldehyde, leading to the formation of formic acid. Since formic acid cannot be metabolized by humans, it causes toxic effects in the body. Formic acid binds to cytochrome C oxidase, located in the mitochondrial respiratory chain, resulting in cellular adenosine triphosphate (ATP) deficiency, electron transport issues, and a higher concentration of reactive oxygen species. This condition manifests as metabolic acidosis, end-organ failure, central nervous system depression, and vision loss. Visual impairments occur due to the direct effect of methanol or the oxidative damage caused by the toxic metabolite formic acid in retinal pigment epithelial cells and the optic nerve [<xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par20">In cases of methanol poisoning, which have high mortality rates, an effective method has not yet been found. Among the treatment methods used for methanol poisoning, hemodialysis is applied to inhibit the hepatic metabolism of methanol, thus preventing metabolite formation and limiting metabolic acidosis [<xref ref-type="bibr" rid="CR17">17</xref>]. Additionally, specific antidotes such as ethanol and fomepizole are administered to try to prevent the formation of formic acid, but these molecules are not effective against ocular toxicity. Intravenous methylprednisolone or erythropoietin applications are also being attempted for methanol induced optic neuropathy [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par21">Some experimental studies suggest that antioxidant molecules and neuroprotective agents may potentially be effective in the treatment of methanol induced optic neuropathy. &#304;&#231;el and al. [<xref ref-type="bibr" rid="CR20">20</xref>] have argued that intravenous ATP administration in experimental methanol poisoning leads to significant improvements in the optic nerve and oxidative stress parameters. Ta&#351;l&#305; and al. [<xref ref-type="bibr" rid="CR21">21</xref>] have advocated for the effectiveness of Rutin usage in optic neuropathy due to its anti-inflammatory effects and its ability to reduce oxidative stress.</p><p id="Par22">We utilized melatonin, a neurohormone secreted via the pineal gland, which is extensively researched for various aspects related to the eye, in our study [<xref ref-type="bibr" rid="CR15">15</xref>]. Melatonin possesses numerous properties such as anti-inflammatory, antioxidant, immune modulating, and free radical scavenging capabilities [<xref ref-type="bibr" rid="CR22">22</xref>]. Additionally, it exerts a stimulatory effect on neuronal branching, myelination, and maturation of oligodendrocytes, displaying protective effects on neurons [<xref ref-type="bibr" rid="CR23">23</xref>]. The potent neuroprotective activity of melatonin arises from the combination of its anti-inflammatory and antioxidant effects.</p><p id="Par23">In studies on oxidative stress parameters in alcohol poisoning, a significant decrease in total antioxidant values &#8203;&#8203;was detected in the neural tissue of rats, and strong evidence was presented for the involvement of the inflammatory process [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. In this context, we examined the effects of melatonin on methanol poisoning-induced optic neuropathy in our study. Our findings support the positive effects of melatonin on the thickness of the optic nerve, glial cell degeneration, RBC oxidative damage and inflammation.</p><p id="Par24">It is known that melatonin is considered a neuroprotective treatment in the eye due to its ability to reduce microglial activation. Increased microglial activation can lead to tissue damage and neuronal cell death by increasing the release of inflammatory cytokines [<xref ref-type="bibr" rid="CR24">24</xref>]. Microglial activation is associated with retinal ganglion cell (RGC) death. Melatonin therapy may exhibit a neuroprotective effect by regulating microglial activation and inhibiting the release of proinflammatory cytokines [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par25">In an experimental study, melatonin therapy has been observed to increase the survival rate of RGCs and improve retinal function. This success has been attributed to the regulation of microglial activation and the inhibition of the TNF&#945;-RGC p38 MAPK signaling pathway, thereby reducing apoptosis and necrosis of retinal cells [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par26">In our study, significantly less susceptibility was detected in both RGCs and optic nerve glial cells, supporting the notion of melatonin&#8217;s microglial inhibition.</p><p id="Par27">Our study has some limitations. One of them is the relatively low number of rats in the experimental study; however, we aimed to use the minimum number of animals to uphold animal rights. Another limitation is that the experimental conditions did not exactly replicate the clinical scenario. Nevertheless, the obtained results could serve as a basis for further investigation into the effects of melatonin therapy on methanol poisoning-induced optic neuropathy.</p><p id="Par28">In conclusion, histopathological evaluations of the optic nerve support the promising effects of melatonin in the treatment of methanol-induced optic neuropathy. To the best of our knowledge, this study is the first to assess the role of melatonin in optic neuropathy in the literature. Future studies should include larger-scale and randomized controlled trials to better understand the effectiveness and safety of melatonin therapy.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>All authors contributed to the conception and design of the study. Material preparation, data collection, and analysis were performed as previously described by Konuk et al. The first draft of the manuscript was written by &#350;erife G&#252;lhan Konuk, and all the authors commented on the previous versions of the manuscript. All the authors have read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by the Scientific and Technological Research Council of T&#252;rkiye (T&#220;B&#304;TAK). Tokat Gaziosmanpa&#351;a University Scientific Research Project was supported financially.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Confict of interest</title><p id="Par29">The authors declare that they have no confict of interest.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par30">The study was approved by the Animal Experimentation Ethics Committee of Tokat Gaziosmanpa&#351;a University (Approval No: 2022 HADYEK-09).</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalili</surname><given-names>MR</given-names></name><name name-style="western"><surname>Sadati</surname><given-names>MS</given-names></name><name name-style="western"><surname>Jahanbani-Ardakani</surname><given-names>H</given-names></name></person-group><article-title>Outbreak of methanol-induced optic neuropathy amid COVID-19 pandemic</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2021</year><volume>259</volume><issue>5</issue><fpage>1375</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1007/s00417-020-04918-y</pub-id><pub-id pub-id-type="pmid">32910310</pub-id><pub-id pub-id-type="pmcid">PMC7481344</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Khalili MR, Sadati MS, Jahanbani-Ardakani H (2021) Outbreak of methanol-induced optic neuropathy amid COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol 259(5):1375&#8211;1376<pub-id pub-id-type="pmid">32910310</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00417-020-04918-y</pub-id><pub-id pub-id-type="pmcid">PMC7481344</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>JY</given-names></name><name name-style="western"><surname>Ho</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lin</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>CC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CC</given-names></name></person-group><article-title>Association between acute methanol poisoning and subsequent mortality: a nationwide study in Taiwan</article-title><source>BMC Public Health</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>985</fpage><pub-id pub-id-type="doi">10.1186/s12889-018-5918-3</pub-id><pub-id pub-id-type="pmid">30086726</pub-id><pub-id pub-id-type="pmcid">PMC6081913</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Chung JY, Ho CH, Chen YC, Chen JH, Lin HJ, Wang JJ, Hsu CC, Huang CC (2018) Association between acute methanol poisoning and subsequent mortality: a nationwide study in Taiwan. BMC Public Health 18(1):985<pub-id pub-id-type="pmid">30086726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12889-018-5918-3</pub-id><pub-id pub-id-type="pmcid">PMC6081913</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liberski</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaluzny</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Koci&#281;cki</surname><given-names>J</given-names></name></person-group><article-title>Methanol-induced optic neuropathy: a still-present problem</article-title><source>Arch Toxicol</source><year>2022</year><volume>96</volume><issue>2</issue><fpage>431</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1007/s00204-021-03202-0</pub-id><pub-id pub-id-type="pmid">34988610</pub-id><pub-id pub-id-type="pmcid">PMC8731680</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Liberski S, Kaluzny BJ, Koci&#281;cki J (2022) Methanol-induced optic neuropathy: a still-present problem. Arch Toxicol 96(2):431&#8211;451<pub-id pub-id-type="pmid">34988610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-021-03202-0</pub-id><pub-id pub-id-type="pmcid">PMC8731680</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hovda</surname><given-names>KE</given-names></name><name name-style="western"><surname>Hunderi</surname><given-names>OH</given-names></name><name name-style="western"><surname>Tafjord</surname><given-names>AB</given-names></name><name name-style="western"><surname>Dunlop</surname><given-names>O</given-names></name><name name-style="western"><surname>Rudberg</surname><given-names>N</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>D</given-names></name></person-group><article-title>Methanol outbreak in Norway 2002&#8211;2004: epidemiology, clinical features and prognostic signs</article-title><source>J Intern Med</source><year>2005</year><volume>258</volume><issue>2</issue><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2005.01521.x</pub-id><pub-id pub-id-type="pmid">16018795</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Hovda KE, Hunderi OH, Tafjord AB, Dunlop O, Rudberg N, Jacobsen D (2005) Methanol outbreak in Norway 2002&#8211;2004: epidemiology, clinical features and prognostic signs. J Intern Med 258(2):181&#8211;190<pub-id pub-id-type="pmid">16018795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2796.2005.01521.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#233;garbane</surname><given-names>B</given-names></name><name name-style="western"><surname>Borron</surname><given-names>SW</given-names></name><name name-style="western"><surname>Baud</surname><given-names>FJ</given-names></name></person-group><article-title>Current recommendations for treatment of severe toxic alcohol poisonings</article-title><source>Intensive Care Med</source><year>2005</year><volume>31</volume><issue>2</issue><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1007/s00134-004-2521-0</pub-id><pub-id pub-id-type="pmid">15627163</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">M&#233;garbane B, Borron SW, Baud FJ (2005) Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 31(2):189&#8211;195<pub-id pub-id-type="pmid">15627163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00134-004-2521-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakharov</surname><given-names>S</given-names></name><name name-style="western"><surname>Pelclova</surname><given-names>D</given-names></name><name name-style="western"><surname>Diblik</surname><given-names>P</given-names></name><name name-style="western"><surname>Urban</surname><given-names>P</given-names></name><name name-style="western"><surname>Kuthan</surname><given-names>P</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>O</given-names></name><name name-style="western"><surname>Kotikova</surname><given-names>K</given-names></name><name name-style="western"><surname>Navratil</surname><given-names>T</given-names></name><name name-style="western"><surname>Komarc</surname><given-names>M</given-names></name><name name-style="western"><surname>Belacek</surname><given-names>J</given-names></name><name name-style="western"><surname>Seidl</surname><given-names>Z</given-names></name><name name-style="western"><surname>Vaneckova</surname><given-names>M</given-names></name><name name-style="western"><surname>Hubacek</surname><given-names>JA</given-names></name><name name-style="western"><surname>Bezdicek</surname><given-names>O</given-names></name><name name-style="western"><surname>Klempir</surname><given-names>J</given-names></name><name name-style="western"><surname>Yurchenko</surname><given-names>M</given-names></name><name name-style="western"><surname>Ruzicka</surname><given-names>E</given-names></name><name name-style="western"><surname>Miovsky</surname><given-names>M</given-names></name><name name-style="western"><surname>Janikova</surname><given-names>B</given-names></name><name name-style="western"><surname>Hovda</surname><given-names>KE</given-names></name></person-group><article-title>Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients</article-title><source>Clin Toxicol (Phila)</source><year>2015</year><volume>53</volume><issue>9</issue><fpage>884</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.3109/15563650.2015.1086488</pub-id><pub-id pub-id-type="pmid">26364866</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Zakharov S, Pelclova D, Diblik P, Urban P, Kuthan P, Nurieva O, Kotikova K, Navratil T, Komarc M, Belacek J, Seidl Z, Vaneckova M, Hubacek JA, Bezdicek O, Klempir J, Yurchenko M, Ruzicka E, Miovsky M, Janikova B, Hovda KE (2015) Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients. Clin Toxicol (Phila) 53(9):884&#8211;892<pub-id pub-id-type="pmid">26364866</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/15563650.2015.1086488</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>W</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name></person-group><article-title>Therapeutic effects of melatonin on ocular diseases: knowledge map and perspective</article-title><source>Front Pharmacol</source><year>2021</year><volume>12</volume><fpage>721869</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.721869</pub-id><pub-id pub-id-type="pmid">34795578</pub-id><pub-id pub-id-type="pmcid">PMC8593251</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Yu H, Wang Q, Wu W, Zeng W, Feng Y (2021) Therapeutic effects of melatonin on ocular diseases: knowledge map and perspective. Front Pharmacol 12:721869<pub-id pub-id-type="pmid">34795578</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2021.721869</pub-id><pub-id pub-id-type="pmcid">PMC8593251</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayo</surname><given-names>JC</given-names></name><name name-style="western"><surname>Sainz</surname><given-names>RM</given-names></name></person-group><article-title>Melatonin from an antioxidant to a classic hormone or a tissue factor: experimental and clinical aspects 2019</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>10</issue><fpage>3645</fpage><pub-id pub-id-type="doi">10.3390/ijms21103645</pub-id><pub-id pub-id-type="pmid">32455655</pub-id><pub-id pub-id-type="pmcid">PMC7279336</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Mayo JC, Sainz RM (2020) Melatonin from an antioxidant to a classic hormone or a tissue factor: experimental and clinical aspects 2019. Int J Mol Sci 21(10):3645<pub-id pub-id-type="pmid">32455655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21103645</pub-id><pub-id pub-id-type="pmcid">PMC7279336</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkozi</surname><given-names>HA</given-names></name><name name-style="western"><surname>Perez de Lara</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Pintor</surname><given-names>J</given-names></name></person-group><article-title>Melatonin synthesis in the human ciliary body triggered by TRPV4 activation: Involvement of AANAT phosphorylation</article-title><source>Exp Eye Res</source><year>2017</year><volume>162</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2017.06.018</pub-id><pub-id pub-id-type="pmid">28655604</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Alkozi HA, Perez de Lara MJ, Pintor J (2017) Melatonin synthesis in the human ciliary body triggered by TRPV4 activation: Involvement of AANAT phosphorylation. Exp Eye Res 162:1&#8211;8<pub-id pub-id-type="pmid">28655604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.exer.2017.06.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savaskan</surname><given-names>E</given-names></name><name name-style="western"><surname>Wirz-Justice</surname><given-names>A</given-names></name><name name-style="western"><surname>Olivieri</surname><given-names>G</given-names></name><name name-style="western"><surname>Pache</surname><given-names>M</given-names></name><name name-style="western"><surname>Kr&#228;uchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Brydon</surname><given-names>L</given-names></name><name name-style="western"><surname>Jockers</surname><given-names>R</given-names></name><name name-style="western"><surname>M&#252;ller-Spahn</surname><given-names>F</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>P</given-names></name></person-group><article-title>Distribution of melatonin MT1 receptor immunoreactivity in human retina</article-title><source>J Histochem Cytochem</source><year>2002</year><volume>50</volume><issue>4</issue><fpage>519</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1177/002215540205000408</pub-id><pub-id pub-id-type="pmid">11897804</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Savaskan E, Wirz-Justice A, Olivieri G, Pache M, Kr&#228;uchi K, Brydon L, Jockers R, M&#252;ller-Spahn F, Meyer P (2002) Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Cytochem 50(4):519&#8211;526<pub-id pub-id-type="pmid">11897804</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/002215540205000408</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narita</surname><given-names>M</given-names></name><name name-style="western"><surname>Miyoshi</surname><given-names>K</given-names></name><name name-style="western"><surname>Narita</surname><given-names>M</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name></person-group><article-title>Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat</article-title><source>Neurosci Lett</source><year>2007</year><volume>414</volume><issue>1</issue><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2006.10.062</pub-id><pub-id pub-id-type="pmid">17284346</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Narita M, Miyoshi K, Narita M, Suzuki T (2007) Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat. Neurosci Lett 414(1):21&#8211;25<pub-id pub-id-type="pmid">17284346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neulet.2006.10.062</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eells</surname><given-names>JT</given-names></name><name name-style="western"><surname>Henry</surname><given-names>MM</given-names></name><name name-style="western"><surname>Lewandowski</surname><given-names>MF</given-names></name><name name-style="western"><surname>Seme</surname><given-names>MT</given-names></name><name name-style="western"><surname>Murray</surname><given-names>TG</given-names></name></person-group><article-title>Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity</article-title><source>Neurotoxicology</source><year>2000</year><volume>21</volume><issue>3</issue><fpage>321</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">10894122</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Eells JT, Henry MM, Lewandowski MF, Seme MT, Murray TG (2000) Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity. Neurotoxicology 21(3):321&#8211;330<pub-id pub-id-type="pmid">10894122</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Bakary</surname><given-names>AA</given-names></name><name name-style="western"><surname>El-Dakrory</surname><given-names>SA</given-names></name><name name-style="western"><surname>Attalla</surname><given-names>SM</given-names></name><name name-style="western"><surname>Hasanein</surname><given-names>NA</given-names></name><name name-style="western"><surname>Malek</surname><given-names>HA</given-names></name></person-group><article-title>Ranitidine as an alcohol dehydrogenase inhibitor in acute methanol toxicity in rats</article-title><source>Hum Exp Toxicol</source><year>2010</year><volume>29</volume><issue>2</issue><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1177/0960327109353777</pub-id><pub-id pub-id-type="pmid">20026516</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">El-Bakary AA, El-Dakrory SA, Attalla SM, Hasanein NA, Malek HA (2010) Ranitidine as an alcohol dehydrogenase inhibitor in acute methanol toxicity in rats. Hum Exp Toxicol 29(2):93&#8211;101<pub-id pub-id-type="pmid">20026516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0960327109353777</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahiskali</surname><given-names>I</given-names></name><name name-style="western"><surname>Pinar</surname><given-names>CL</given-names></name><name name-style="western"><surname>Kiki</surname><given-names>M</given-names></name><name name-style="western"><surname>Cankaya</surname><given-names>M</given-names></name><name name-style="western"><surname>Kunak</surname><given-names>CS</given-names></name><name name-style="western"><surname>Altuner</surname><given-names>D</given-names></name></person-group><article-title>Effect of taxifolin on methanol-induced oxidative and inflammatory optic nerve damage in rats</article-title><source>Cutan Ocul Toxicol</source><year>2019</year><volume>38</volume><issue>4</issue><fpage>384</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1080/15569527.2019.1637348</pub-id><pub-id pub-id-type="pmid">31242797</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ahiskali I, Pinar CL, Kiki M, Cankaya M, Kunak CS, Altuner D (2019) Effect of taxifolin on methanol-induced oxidative and inflammatory optic nerve damage in rats. Cutan Ocul Toxicol 38(4):384&#8211;389<pub-id pub-id-type="pmid">31242797</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15569527.2019.1637348</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liesivuori</surname><given-names>J</given-names></name><name name-style="western"><surname>Savolainen</surname><given-names>H</given-names></name></person-group><article-title>Methanol and formic acid toxicity: biochemical mechanisms</article-title><source>Pharmacol Toxicol</source><year>1991</year><volume>69</volume><issue>3</issue><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0773.1991.tb01290.x</pub-id><pub-id pub-id-type="pmid">1665561</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Liesivuori J, Savolainen H (1991) Methanol and formic acid toxicity: biochemical mechanisms. Pharmacol Toxicol 69(3):157&#8211;163<pub-id pub-id-type="pmid">1665561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0773.1991.tb01290.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabay</surname><given-names>O</given-names></name><name name-style="western"><surname>Talmon</surname><given-names>A</given-names></name><name name-style="western"><surname>Tsumi</surname><given-names>E</given-names></name><name name-style="western"><surname>Bartal</surname><given-names>C</given-names></name></person-group><article-title>Reversal of severe methanol induced visual impairment due to prompt hemodialysis</article-title><source>J Clin Toxicol</source><year>2018</year><volume>8</volume><fpage>379</fpage><pub-id pub-id-type="doi">10.4172/2161-0495.1000379</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Gabay O, Talmon A, Tsumi E, Bartal C (2018) Reversal of severe methanol induced visual impairment due to prompt hemodialysis. J Clin Toxicol 8:379</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karimi</surname><given-names>S</given-names></name><name name-style="western"><surname>Arabi</surname><given-names>A</given-names></name><name name-style="western"><surname>Shahraki</surname><given-names>T</given-names></name></person-group><article-title>Alcohol and the eye</article-title><source>J Ophthalmic Vis Res</source><year>2021</year><volume>16</volume><issue>2</issue><fpage>260</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.18502/jovr.v16i2.9089</pub-id><pub-id pub-id-type="pmid">34055263</pub-id><pub-id pub-id-type="pmcid">PMC8126742</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Karimi S, Arabi A, Shahraki T (2021) Alcohol and the eye. J Ophthalmic Vis Res 16(2):260&#8211;270<pub-id pub-id-type="pmid">34055263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18502/jovr.v16i2.9089</pub-id><pub-id pub-id-type="pmcid">PMC8126742</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>M</given-names></name><name name-style="western"><surname>Shikoh</surname><given-names>I</given-names></name><name name-style="western"><surname>Saleem</surname><given-names>A</given-names></name></person-group><article-title>Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning</article-title><source>Indian J Ophthalmol</source><year>2006</year><volume>54</volume><issue>1</issue><fpage>68</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.4103/0301-4738.21628</pub-id><pub-id pub-id-type="pmid">16531683</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Shukla M, Shikoh I, Saleem A (2006) Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning. Indian J Ophthalmol 54(1):68&#8211;69<pub-id pub-id-type="pmid">16531683</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0301-4738.21628</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pakdel</surname><given-names>F</given-names></name><name name-style="western"><surname>Sanjari</surname><given-names>MS</given-names></name><name name-style="western"><surname>Naderi</surname><given-names>A</given-names></name><name name-style="western"><surname>Pirmarzdashti</surname><given-names>N</given-names></name><name name-style="western"><surname>Haghighi</surname><given-names>A</given-names></name><name name-style="western"><surname>Kashkouli</surname><given-names>MB</given-names></name></person-group><article-title>Erythropoietin in treatment of methanol optic neuropathy</article-title><source>J Neuroophthalmol</source><year>2018</year><volume>38</volume><issue>2</issue><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1097/WNO.0000000000000614</pub-id><pub-id pub-id-type="pmid">29300238</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Pakdel F, Sanjari MS, Naderi A, Pirmarzdashti N, Haghighi A, Kashkouli MB (2018) Erythropoietin in treatment of methanol optic neuropathy. J Neuroophthalmol 38(2):167&#8211;171<pub-id pub-id-type="pmid">29300238</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/WNO.0000000000000614</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Icel</surname><given-names>E</given-names></name><name name-style="western"><surname>Suleyman</surname><given-names>H</given-names></name><name name-style="western"><surname>Yazici</surname><given-names>GN</given-names></name><name name-style="western"><surname>Bakan</surname><given-names>N</given-names></name><name name-style="western"><surname>Sunar</surname><given-names>M</given-names></name></person-group><article-title>Effects of adenosine triphosphate on methanol-induced experimental optic nerve damage in rats: biochemical and histopathological evaluation</article-title><source>Cutan Ocul Toxicol</source><year>2020</year><volume>39</volume><issue>3</issue><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1080/15569527.2020.1778017</pub-id><pub-id pub-id-type="pmid">32543996</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Icel E, Suleyman H, Yazici GN, Bakan N, Sunar M (2020) Effects of adenosine triphosphate on methanol-induced experimental optic nerve damage in rats: biochemical and histopathological evaluation. Cutan Ocul Toxicol 39(3):244&#8211;248<pub-id pub-id-type="pmid">32543996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15569527.2020.1778017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ta&#351;l&#305;</surname><given-names>NG</given-names></name><name name-style="western"><surname>&#199;imen</surname><given-names>FK</given-names></name><name name-style="western"><surname>Karakurt</surname><given-names>Y</given-names></name><name name-style="western"><surname>U&#231;ak</surname><given-names>T</given-names></name><name name-style="western"><surname>Mammadov</surname><given-names>R</given-names></name><name name-style="western"><surname>S&#252;leyman</surname><given-names>B</given-names></name><name name-style="western"><surname>Kurt</surname><given-names>N</given-names></name><name name-style="western"><surname>S&#252;leyman</surname><given-names>H</given-names></name></person-group><article-title>Protective effects of Rutin against methanol induced acute toxic optic neuropathy: an experimental study</article-title><source>Int J Ophthalmol</source><year>2018</year><volume>11</volume><issue>5</issue><fpage>780</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">29862175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18240/ijo.2018.05.10</pub-id><pub-id pub-id-type="pmcid">PMC5957028</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Ta&#351;l&#305; NG, &#199;imen FK, Karakurt Y, U&#231;ak T, Mammadov R, S&#252;leyman B, Kurt N, S&#252;leyman H (2018) Protective effects of Rutin against methanol induced acute toxic optic neuropathy: an experimental study. Int J Ophthalmol 11(5):780&#8211;785<pub-id pub-id-type="pmid">29862175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18240/ijo.2018.05.10</pub-id><pub-id pub-id-type="pmcid">PMC5957028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bettahi</surname><given-names>I</given-names></name><name name-style="western"><surname>Pozo</surname><given-names>D</given-names></name><name name-style="western"><surname>Osuna</surname><given-names>C</given-names></name><name name-style="western"><surname>Reiter</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Acu&#241;a-Castroviejo</surname><given-names>D</given-names></name><name name-style="western"><surname>Guerrero</surname><given-names>JM</given-names></name></person-group><article-title>Melatonin reduces nitric oxide synthase activity in rat hypothalamus</article-title><source>J Pineal Res</source><year>1996</year><volume>20</volume><issue>4</issue><fpage>205</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1111/j.1600-079X.1996.tb00260.x</pub-id><pub-id pub-id-type="pmid">8836954</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Bettahi I, Pozo D, Osuna C, Reiter RJ, Acu&#241;a-Castroviejo D, Guerrero JM (1996) Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 20(4):205&#8211;210<pub-id pub-id-type="pmid">8836954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-079x.1996.tb00260.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esposito</surname><given-names>E</given-names></name><name name-style="western"><surname>Cuzzocrea</surname><given-names>S</given-names></name></person-group><article-title>Antiinflammatory activity of melatonin in central nervous system</article-title><source>Curr Neuropharmacol</source><year>2010</year><volume>8</volume><issue>3</issue><fpage>228</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.2174/157015910792246155</pub-id><pub-id pub-id-type="pmid">21358973</pub-id><pub-id pub-id-type="pmcid">PMC3001216</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Esposito E, Cuzzocrea S (2010) Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 8(3):228&#8211;242. 10.2174/157015910792246155<pub-id pub-id-type="pmid">21358973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/157015910792246155</pub-id><pub-id pub-id-type="pmcid">PMC3001216</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hickman</surname><given-names>S</given-names></name><name name-style="western"><surname>Izzy</surname><given-names>S</given-names></name><name name-style="western"><surname>Sen</surname><given-names>P</given-names></name><name name-style="western"><surname>Morsett</surname><given-names>L</given-names></name><name name-style="western"><surname>El Khoury</surname><given-names>J</given-names></name></person-group><article-title>Microglia in neurodegeneration</article-title><source>Nat Neurosci</source><year>2018</year><volume>21</volume><issue>10</issue><fpage>1359</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0242-x</pub-id><pub-id pub-id-type="pmid">30258234</pub-id><pub-id pub-id-type="pmcid">PMC6817969</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21(10):1359&#8211;1369<pub-id pub-id-type="pmid">30258234</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41593-018-0242-x</pub-id><pub-id pub-id-type="pmcid">PMC6817969</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>B</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>B</given-names></name></person-group><article-title>Melatonin protects against NMDA-induced retinal ganglion cell injury by regulating the microglia-TNF&#945;-RGC p38 MAPK pathway</article-title><source>Int Immunopharmacol</source><year>2023</year><volume>118</volume><fpage>109976</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2023.109976</pub-id><pub-id pub-id-type="pmid">37098655</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Zou J, Yang J, Chen B, Jiang J, Liu J, Wang C, Yu J, Peng Q, Zeng J, Zhang L, Jiang B (2023) Melatonin protects against NMDA-induced retinal ganglion cell injury by regulating the microglia-TNF&#945;-RGC p38 MAPK pathway. Int Immunopharmacol 118:109976<pub-id pub-id-type="pmid">37098655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2023.109976</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>